At the end of the latest market close, Clarus Therapeutics Holdings Inc. (CRXT) was valued at $4.01. In that particular session, Stock kicked-off at the price of $4.02 while reaching the peak value of $6.77 and lowest value recorded on the day was $4.00. The stock current value is $5.74.Recently in News on November 18, 2021, Clarus Therapeutics Reports Third Quarter 2021 Financial and Operating Results. Third quarter 2021 revenue increased 93% year-over-year to $4.3 million. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clarus Therapeutics Holdings Inc. shares are logging -81.63% during the 52-week period from high price, and 67.35% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.43 and $31.24.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 17814327 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Clarus Therapeutics Holdings Inc. (CRXT) recorded performance in the market was -43.61%, having the revenues showcasing -45.07% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 132.71M.
Specialists analysis on Clarus Therapeutics Holdings Inc. (CRXT)
During the last month, 3 analysts gave the Clarus Therapeutics Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.32, with a change in the price was noted -4.35. In a similar fashion, Clarus Therapeutics Holdings Inc. posted a movement of -43.11% for the period of last 100 days, recording 1,684,438 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CRXT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Clarus Therapeutics Holdings Inc. (CRXT)
Raw Stochastic average of Clarus Therapeutics Holdings Inc. in the period of last 50 days is set at 37.20%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 44.53%. In the last 20 days, the company’s Stochastic %K was 19.38% and its Stochastic %D was recorded 16.06%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -43.61%. The shares 18.60% in the 7-day charts and went down by 43.14% in the period of the last 30 days. Common stock shares were lifted by -45.07% during last recorded quarter.